ACXP
Acurx Pharmaceuticals, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Acurx Pharmaceuticals (ACXP) Stock: Buy, Sell, or Hold?
$0.99
-0.05 (-4.37%)
▼
5d:
+4.16%
30d:
-14.35%
90d:
-29.39%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (77%)
Quality Score
46/100
Position
OVERSOLD
30-Day Fair Range
$1.02 – $1.22
Position: OVERSOLD
Forward P/E & Valuation
-0.6x
Next 12M consensus est.
Wall Street Target
$17.00
+1625.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.95 / $1.12
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ACXP shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ACXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ACXP is currently trading at $0.98, which is considered oversold relative to its 30-day fair value range of $1.02 to $1.22.
Technical Outlook: Technically, ACXP is in a strong downtrend. Immediate support is located at $0.95, while resistance sits at $1.12. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $17.00 (+1625.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACXP is in a strong downtrend. Immediate support is located at $0.95, while resistance sits at $1.12. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $17.00 (+1625.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.02 -
$1.22
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$1.02 -
$1.22
Current vs Trading Range
OVERSOLD
Support Level
$0.95
Resistance Level
$1.12
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.4%)
- BULLISH: Trading 1625.9% below Wall St target ($17.00)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.56
Wall Street Target
$17.00
(+1625.9%)
Share ACXP Analysis
Share this live ACXP analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ACXP)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment on StockTwits regarding $ACXP being run by con artists, no recent news articles available.
Key Retail Themes:
Negative perception of company management
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 8:07 PM ET
Data refreshes hourly during market hours. Next update: 9:07 PM
Data refreshes hourly during market hours. Next update: 9:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACXP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ACXP Research Pages
